DSR - DRUGS AND SAVINGS REPORT Trademark

Trademark Overview

On Tuesday, August 17, 2021, a trademark application was filed for DSR - DRUGS AND SAVINGS REPORT with the United States Patent and Trademark Office. The USPTO has given the DSR - DRUGS AND SAVINGS REPORT trademark a serial number of 90887701. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 9, 2024. This trademark is owned by Gemini Health LLC. The DSR - DRUGS AND SAVINGS REPORT trademark is filed in the Advertising, Business and Retail Services category with the following description:

Medical cost management; Pharmaceutical cost management services and drug utilization review services
dsr - drugs and savings report

General Information

Serial Number90887701
Word MarkDSR - DRUGS AND SAVINGS REPORT
Filing DateTuesday, August 17, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements

Goods and ServicesMedical cost management; Pharmaceutical cost management services and drug utilization review services
NOT AVAILABLE"DRUG AND SAVINGS REPORT"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGemini Health LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSausalito, CA 94965
Party NameGemini Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSausalito, CA 94965

Trademark Events

Event DateEvent Description
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Friday, August 20, 2021NEW APPLICATION ENTERED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 10, 2022NON-FINAL ACTION WRITTEN
Friday, June 10, 2022NON-FINAL ACTION E-MAILED
Friday, June 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 16, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 16, 2023SOU EXTENSION 1 FILED
Monday, October 16, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU EXTENSION 2 GRANTED
Thursday, April 4, 2024SOU EXTENSION 2 FILED
Wednesday, October 9, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2024SOU EXTENSION 3 FILED
Wednesday, October 9, 2024SOU EXTENSION 3 GRANTED
Wednesday, November 13, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

report savings drugs services management cost review utilization pharmaceutical medical drug